Introduction
Rapid advancement of medical imaging in the last few decades has significantly enhanced the role of imaging in medicine. Imaging plays an integral role in the evaluation of many of the diseases confronted by the otolaryngologist. It is performed for diagnosis, staging of tumors, assessing efficacy of therapy, follow-up, and guidance for procedures.
Imaging in the head and neck, like no other area of the human body, differs considerably based on the specific anatomic area of interest. In fact, unique imaging protocols have been designed for at least 9 specific areas of the head and neck. These include from superior to inferior the cerebellopontine angle-internal auditory canal (CPA-IAC), skull base, temporal bone, orbit, sinus and nose, suprahyoid neck, infrahyoid neck, pharynx, and larynx. Clinical history and physical findings in combination with high-resolution imaging available today create the possibility of a highly specific clinical-radiologic diagnosis. Computed tomography (CT) and magnetic resonance (MR) form the backbone of the imaging work-up of patients with diseases of the head and neck.
Imaging Modalities
In the past, radiography ("plain films" and "tomography") played a significant, but not very effective, role in imaging of the head and neck. With the emergence of advanced imaging, the role of radiography has virtually disappeared. Currently, CT, MR, and PET/CT are the most commonly performed imaging modalities for diseases of the head and neck. Modern multidetector, multiplanar CT now creates exquisite anatomical detail allowing the diagnosis of very small lesions, such as temporal bone otosclerosis, not thought possible even a decade ago. MR techniques, such as multiplanar thin-section enhanced, fat-saturated T1, allow the imager to identify subtle findings, such as perineural tumor spread along extracranial portions of cranial nerves. The use of a variety of MR sequences (T1, T2, FLAIR, GRE, enhanced T1 fat-saturated) permit the imager to differentiate tissue types, such as normal muscle from tumor. Other unique MR sequences can suggest specific diagnoses, such as the case of diffusion weighted imaging (DWI) MR sequence being highly specific for the diagnosis of epidermoid.
Likewise, fluorodeoxyglucose positron emission tomography (FDG-PET)/CT imaging has a distinct role in the imaging of patients with squamous cell carcinoma (SCCa) staging and follow-up. Metabolically active primary tumor and malignant nodes mapped against an underlying contrast-enhanced CT can help differentiate normal tonsillar tissue and reactive nodes from invasive SCCa primary and metastatic nodes. Ultrasound and color Doppler are useful in evaluating the head and neck vasculature. Ultrasound is also used to evaluate neck masses and localize them for fine-needle aspiration.
CT
CT technology relies on the same physical principles as x-rays. The differential absorption of the x-ray beam by different tissues produces varied levels of density in the image (see Table 1 ), which on CT scans are measured in Hounsfield units (HU). This can be displayed in cross-sectional format or in multiple planes. Multidetector CT has enlarged the capability of CT with faster scans, greater spatial resolution, and multiplanar reformations.
Nonenhanced CT (NECT)
The role for NECT in head and neck imaging is small. A ductal stone, lesion chondroid (cartilaginous) or osteoid (bony) matrix, or radiopaque foreign body can be seen in the presence of contrast in the vessels of the neck. As a rule, contrast-enhanced CT (CECT) is done in all soft tissue neck imaging examinations if renal function and allergy history allow.
CECT
CECT is the workhorse in imaging the soft tissues of the extracranial head and neck. CECT is often preferred to MR because the images are acquired rapidly (fractions of seconds), whereas MR sequences require the patient to remain still for 3-5 minutes at a time (see Table 2 ). This is especially true in the infrahyoid neck area where movement artifact degrades MR images considerably.
CECT is routinely used as a starting exam in most patients who need imaging of the head and neck to evaluate a deep tissue clinical question. Staging and follow-up of pharyngeal and laryngeal SCCa, abscess search, and suspected mass evaluation are but a few of the uses of CECT.
Thin-Section Bone CT
Temporal bone, skull base, and sinonasal CT evaluations begin with unenhanced, multiplanar, thin-section, and bone algorithm CT. Slice thickness varies by area (temporal bone: 0.6 mm; skull base: 1-2 mm; sinuses: 2-3 mm). If soft tissue questions remain after the CT is completed in these 3 areas, enhanced fat-saturated T1 MR is used to analyze tissue type and extent instead of repeating the CT with contrast at a later date.
CT Angiogram (CTA)
For many, CTA remains the study of choice for all emergent and nonemergent vascular conditions, such as carotid atherosclerotic stenosis, dissection, and pseudoaneurysm. It can also be used in the setting of a suspected dural arteriovenous fistula and carotid cavernous fistula. Other uses of CTA include assessing the integrity of the internal carotid artery when it is involved by dural tumors, such as meningioma or invasive neck SCCa. When significant neck trauma suggests the possibility of arterial injury, CTA is ideal to answer this clinical question. CTA is fast and less prone to artifact than MR angiography (MRA). A combined CTA of the head and neck, from the aortic arch to the cranial vertex, can be obtained with as little as 70 ml of IV contrast in < 15 seconds.
CT Venogram (CTV)
CTV is similar to CTA except for an added delay for optimal visualization of the venous system. It is a fast, reliable modality to exclude dural sinus thrombosis in an emergent setting. It is particularly helpful in the search for venous sinus thrombosis in the posterior fossa and skull base.
MR
The primary origin of the MR signal used to generate clinical images comes from hydrogen nuclei. Hydrogen nuclei consist of a single proton that is constantly spinning. A radio frequency pulse (RF pulse) emitted from the scanner results in some of the hydrogen protons being "knocked" out of alignment with the static magnetic field. As the energy from the RF pulse is dissipated, the hydrogen protons will return to alignment with the static magnetic field. The MR signal is derived from the hydrogen protons as they move back into alignment with the magnetic field. The MR signal is then broken down and spatially located to produce images.
The movement of the neck, which occurs during swallowing, coughing, sneezing, scratching, and breathing, often degrades the diagnostic quality of MR images of the neck. Enhanced fatsaturated MR is preferred over CECT in the suprahyoid neck where movement is less frequent and in the oral cavity when dental amalgam artifact obscures the CT image. MR is also a powerful imaging tool for mass lesions in the CPA-IAC, orbit, skull base, and sinonasal areas.
T1 and T2 are the fundamental parameters of MR and determine the contrast between tissues. MR sequences that emphasize tissue differences in T1 relaxation are called T1 weighted, and those that emphasize T2 relaxation are called T2 weighted. Tissues with short T1 relaxation time, such as fat, melanin, and protein, produce high signal on T1-weighted sequences and appear "bright," whereas fluid is relatively dark. Fluid has a long T2 relaxation time and appears bright on T2-weighted sequences.
Spin-echo and gradient-echo are 2 basic sequences in MR. All other sequences are variations of one of these sequences and are used to better characterize specific tissue types.
Fluid-attenuation inversion recovery (FLAIR) sequence eliminates fluid signal, which thus appears dark. It is useful for highlighting cisternal lesions. "Bright" CSF sulcal signal on FLAIR may suggest leptomeningeal disease with replacement of normal CSF by pus (meningitis), blood (subarachnoid hemorrhage), or tumor cells (leptomeningeal carcinomatosis).
Short-tau inversion recovery (STIR)
sequence is used to eliminate signal from fat. In the head and neck area, STIR often displays fluid-containing lesions (cysts, abscess) as conspicuous high-signal (bright) lesions. It is also used in diagnosing fat-containing lesions like lipoma and dermoid cyst.
Diffusion-weighted imaging (DWI)
shows the molecular motion or diffusion of water protons within tissue. DWI generates diffusion and apparent diffusion coefficient (ADC) maps. ADC is a measure of the magnitude of diffusion. True restricted diffusion will be bright on diffusion and dark on ADC maps. Restricted diffusion can be seen in processes like pyogenic abscess, highly cellular tumor, and epidermoid cyst. Generally, the ADC value of malignant tissue is < the ADC value of benign tumors.
Gradient-echo sequence (GRE)
is sensitive to small amounts of blood breakdown products as well as calcium and metallic deposits, fat, and air. In lesions with blood products (lymphatic malformation, cholesterol granuloma, paraganglioma) or calcifications (osteosarcoma, chondrosarcoma, meningioma), the focal areas of blood will be low signal and bloom on GRE sequences.
MRA
Time-of-flight (TOF) imaging is most commonly used for MRA. Signal in intracranial arteries is related to flow phenomenon, and thus no IV gadolinium is needed. TOF MRA can be performed by both 2D and 3D techniques.
Contrast-enhanced MRA is often used to evaluate the neck vasculature. Contrast-enhanced intracranial MRA is useful in patients with stents &/or coils.
MR Venogram (MRV)
MRV can be performed with 2D/3D TOF techniques, which do not need administration of IV gadolinium. Contrast-enhanced MRV is, however, more robust and is less susceptible to artifacts compared with the TOF techniques.
PET/CT
PET/CT is the best imaging modality for staging, monitoring, and surveillance of advanced head and neck SCCa. It is superior to PET, CECT, or MR imaging alone. It is also superior for identifying 2nd primary tumors.
A basic understanding of the core workings of PET is essential. Fluorodeoxyglucose (FDG) is transported into a cell in the same manner as normal glucose. There, it becomes trapped and accumulates in cells with high glucose metabolism. Fused PET/CT offers the imager combined anatomic and physiologic information. It distinguishes extensive physiologic FDG uptake in the head and neck from true pathologic uptake. Standardized uptake value (SUV) provides a quantified measure of FDG uptake.
The clinical utility of PET/CT for SCCa of the head and neck depends on the size of primary tumor. This technique is most useful for evaluating for nodal and distant metastases with locally advanced T3 or T4 tumors or those with known nodal metastases. It also supplies specific information about the presence of 2nd primary tumors in the body. In the clinical setting of malignant metastatic nodes without a clinically identified primary tumor ("unknown primary"), PET/CT at times will locate the hidden primary tumor.
Pitfalls of PET/CT are multiple. False-positive uptake from normal physiology, inflammation, and posttreatment changes must be guarded against. False-negative uptake from cystic lesions (necrotic primary or nodal metastases), small tumors, and non-FDG-avid tumors may be encountered. Reading head and neck PET/CT scans requires intimate knowledge of head and neck anatomy and tumor behavior for correct interpretation to be rendered.
Ultrasound and Doppler
Grayscale is used to for extracranial atherosclerotic disease and plaque morphology. Color Doppler detects turbulent blood flow. Doppler spectral analysis measures blood flow velocity, which correlates with the degree of vascular stenosis. Ultrasound is also used to evaluate neck masses (especially in children) and localize them for fine-needle aspiration.
Digital Subtraction Angiography (DSA)
DSA is still considered the "gold standard" in vascular imaging. However, DSA is an invasive procedure associated with risk of complication, with 1% overall incidence of neurologic deficit and 0.5% incidence of persistent deficit. CTA and CTV have made the use of DSA for diagnosis extremely limited. Instead, DSA is used to confirm the diagnosis of arteriovenous fistula while at the same time completing endovascular treatment. It is additionally used for preoperative embolization of vascular tumors, such as paraganglioma and meningioma. 
